Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization.
about
The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart developmentSpatiotemporal control over growth factor signaling for therapeutic neovascularizationEarly arterial differentiation and patterning in the avian embryo modelDynamic analysis of vascular morphogenesis using transgenic quail embryosTumor angiogenesis and vascular patterning: a mathematical modelHyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activationVascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesisFlt-1 (VEGFR-1) coordinates discrete stages of blood vessel formationAn anteroposterior wave of vascular inhibitor downregulation signals aortae fusion along the embryonic midline axisDynamic responses of endothelial cells to changes in blood flow during vascular remodeling of the mouse yolk sac.tRNA synthetase counteracts c-Myc to develop functional vasculature.Xenopus Dab2 is required for embryonic angiogenesisMolecular mediators of angiogenesis.Spinal cord stimulation exerts neuroprotective effects against experimental Parkinson's disease.Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle.Early embryonic vascular patterning by matrix-mediated paracrine signalling: a mathematical model study.Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy.The role of FGF and VEGF in angioblast induction and migration during vascular development.Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsiaVEGF-mediated fusion in the generation of uniluminal vascular spheroidsLoss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-AGeometrical microfeature cues for directing tubulogenesis of endothelial cellsThe impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF).Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers.Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.Vascularization of the developing chick limb bud: role of the TGFbeta signalling pathway.The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formationTopical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.Fusion of uniluminal vascular spheroids: a model for assembly of blood vessels.Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.Tying the knot: the cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines.The potential role of vascular endothelial growth factor in the central nervous system.Genetic and epigenetic mechanisms in the early development of the vascular system.Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivoConditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.Antiangiogenic therapy in human gastrointestinal malignancies.Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cellsMicrophthalmia, persistent hyperplastic hyaloid vasculature and lens anomalies following overexpression of VEGF-A188 from the alphaA-crystallin promoter.Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2.
P2860
Q24605541-6D1E0C9E-757F-4468-9FA2-240D444784A6Q24641819-FBB435F0-B4B1-4E77-9C6B-FAC05F1C8285Q27027831-3A5FF767-66E3-473F-ADD8-DC8A5C23AEC4Q27320350-02681876-18F9-4423-957F-4A0B4D156181Q27339985-9DB341BB-2042-4C87-A165-ADCA9A39A64BQ28362045-ECCAC91A-4318-4AD2-8A85-4835D96EA8D3Q28507817-C98A46E0-38A3-4B1D-8E3E-899BBC84AFA6Q30276870-9B63191C-0FDC-4616-918D-7D3832A0093FQ30497126-D861C374-8690-4392-A7CE-32FED9EB0D4FQ30544920-8EC82102-DA15-452B-886E-1F64DEAAF562Q31814854-6CEE1609-FB60-462F-9191-6EB93B1034A8Q33266946-4B5DEF86-FE7B-4348-B4A9-0C45F547D10DQ33639474-8A651D3E-2249-4668-9D71-8D4230170BEBQ33882321-53EC43B2-5A7E-4388-8B8C-710B4189A882Q34023655-71842B88-B3CD-442E-8699-67EEBD81AD6EQ34031278-D47118F4-9C07-4BCD-A0F8-BC5A1AB3E408Q34086442-96A2CADD-3BBD-41BF-9F77-E83171CCF0C8Q34123470-A13F4C41-E3EF-4A14-89D3-FCEA5216B985Q34140082-99F935E0-F3AC-4227-914F-64A921CF4BF0Q34150126-DC376C33-5BC8-4A6B-8572-367B23134A6CQ34331369-B61C91B5-8A61-4114-852B-D4B90A51A230Q34351139-FCED704F-E94A-43F1-A90F-C7BCC3FA9265Q34498455-2CE8B231-6072-43E8-8C3B-A5222990A7EDQ34608643-B0C48879-BA5D-4675-AE63-7D8CAB8AA077Q34835409-6C75DBCA-3BDC-4F01-B900-EF70752ECC45Q35066911-1FC704A4-3081-49C0-B072-66D5D8BA3BF1Q35098106-DDB94945-2873-43C3-8E60-AB9E2614D0EEQ35098397-80D2D767-1913-4ADD-84AC-D0AC52AFB71AQ35223246-9AE6D99B-F62E-4650-A286-B9DD583BEDCBQ35764395-F552C21B-0CFE-4F69-A065-83645F5ED0F3Q35791487-958788E6-BBD5-4D91-B3E6-8A1E4FF19F73Q35895234-6ECECAD0-DE15-4151-93A4-9FB3DD695D44Q35939261-6BE4B0CA-B01E-4485-AD2E-2B5243946AA7Q36379514-C2ADFEF0-EB5E-4FF9-84B2-A895C080C874Q36508351-269AE953-72FA-4E9D-AA00-517C2468E4A7Q36558878-65906DB8-5E64-42DD-9FBC-6111B482375BQ36591067-B3037B85-151F-4FAD-92AC-CDEF97734D22Q36678082-CAA4247B-CA18-4B6B-A970-DFAEC860AB24Q36822355-B776AD8F-99AF-41FF-8F26-C1B3F16E38D3Q37428029-224603B8-DF1B-4A72-A693-6CA961E8E253
P2860
Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Exogenous vascular endothelial ...... embryonic neovascularization.
@ast
Exogenous vascular endothelial ...... embryonic neovascularization.
@en
type
label
Exogenous vascular endothelial ...... embryonic neovascularization.
@ast
Exogenous vascular endothelial ...... embryonic neovascularization.
@en
prefLabel
Exogenous vascular endothelial ...... embryonic neovascularization.
@ast
Exogenous vascular endothelial ...... embryonic neovascularization.
@en
P2860
P356
P1476
Exogenous vascular endothelial ...... embryonic neovascularization.
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.17.7657
P407
P577
1995-08-01T00:00:00Z